Environment & Astrocyte Proinflammation

Environmental factors play a role in neurological diseases and in particular their contribution in astrocyte proinflammation is of interest. The activation of astrocytes may be involved in neuroinflammation and implicated in neurodegenerative diseases. Here is the latest research on environment and astrocyte proinflammation.

December 5, 2009
Open Access

Effects of environmental tobacco smoke on adult rat brain biochemistry

Journal of Molecular Neuroscience : MN
Brian F FullerAndrew K Ottens
January 22, 2019
Open Access

Environmental Control of Astrocyte Pathogenic Activities in CNS Inflammation

Michael A WheelerFrancisco J Quintana
June 9, 2009
Open Access

Early-life experience alters response of developing brain to seizures

Brain Research
Cassandra KazlSookyong Koh
June 18, 2010
Open Access

The neurotoxicity of environmental aluminum is still an issue

Stephen C Bondy
August 31, 2010

Review of fullerene toxicity and exposure--appraisal of a human health risk assessment, based on open literature

Regulatory Toxicology and Pharmacology : RTP
Karin AschbergerFrans M Christensen
August 31, 2020
Open Access

Nrf2/Wnt resilience orchestrates rejuvenation of glia-neuron dialogue in Parkinson's disease

Redox Biology
Bianca Marchetti
August 31, 2016

The Deterioration Seen in Myelin Related Morphophysiology in Vanadium Exposed Rats is Partially Protected by Concurrent Iron Deficiency

Nigerian Journal of Physiological Sciences : Official Publication of the Physiological Society of Nigeria
Ifukibot Levi UsendeJames O Olopade
May 4, 2010

Iron, Lead, and Children's Behavior and Cognition

Annual Review of Nutrition
Katarzyna Kordas
October 7, 2016
Open Access

Environmental control of autoimmune inflammation in the central nervous system

Current Opinion in Immunology
Veit Rothhammer, Francisco J Quintana
September 14, 2006
Open Access

Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway

Annual Review of Pharmacology and Toxicology
Thomas W KenslerShyam Biswal
January 16, 2017

Stem cells for ALS: An overview of possible therapeutic approaches

International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience
Joanna CzarzastaJoanna Wojtkiewicz
August 28, 2007
Open Access

Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention

Experimental Neurology
Malú G TanseyTamy C Frank-Cannon
April 3, 2010
Open Access

Gene-environment interactions: neurodegeneration in non-mammals and mammals

Michael AschnerJames R Connor

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved